Weinreb M, Day P J, Niggli F, Powell J E, Raafat F, Hesseling P B, Schneider J W, Hartley P S, Tzortzatou-Stathopoulou F, Khalek E R, Mangoud A, El-Safy U R, Madanat F, Al Sheyyab M, Mpofu C, Revesz T, Rafii R, Tiedemann K, Waters K D, Barrantes J C, Nyongo A, Riyat M S, Mann J R
Children's Hospital, Ladywood Middleway, Birmingham, UK.
Arch Dis Child. 1996 Jan;74(1):27-31. doi: 10.1136/adc.74.1.27.
Recent studies have suggested that Epstein-Barr virus (EBV) may play a role in the aetiology of Hodgkin's disease. To determine the role of EBV in childhood Hodgkin's disease in different geographical areas, immunohistochemical staining and in situ hybridisation were used to analyse latent membrane protein 1 (LMP 1) and small nuclear non-transcribed RNAs (EBER-1) respectively. Testing for EBV within the Reed-Sternberg and Hodgkin's cells was carried out in childhood Hodgkin's disease from 10 different countries. The proportion of LMP 1 positive cases varied significantly, being 50% of cases from the United Kingdom (38/75), South Africa (9/18), Egypt (7/14), and Jordan (8/16), 60% from the United Arab Emirates (6/10), 70% from Australia (11/16), 81% from Costa Rica (34/42), 88% from Iran (7/8), 90% from Greece (20/22), and 100% of the 56 cases from Kenya. A sensitive polymerase chain reaction based EBV strain typing technique was established using archival tissues. EBV strain type 1 was shown to be predominant in childhood Hodgkin's disease from the United Kingdom, South Africa, Australia, and Greece. Type 2 was predominant in Egypt. EBV strain types 1 and 2 were both detected in some cases of childhood Hodgkin's disease in the United Kingdom, Costa Rica, and Kenya. The high incidence of EBV and the presence especially in developing countries of dual infection with both strain types 1 and 2 may reflect socioeconomic conditions leading to malnutrition induced immunological impairment. The possibility of HIV infection also needs to be explored.
近期研究表明,爱泼斯坦-巴尔病毒(EBV)可能在霍奇金病的病因学中起作用。为确定EBV在不同地理区域儿童霍奇金病中的作用,分别采用免疫组织化学染色和原位杂交技术分析潜伏膜蛋白1(LMP 1)和小核非转录RNA(EBER-1)。对来自10个不同国家的儿童霍奇金病患者的里德-斯腾伯格细胞和霍奇金细胞进行了EBV检测。LMP 1阳性病例的比例差异显著,英国(38/75)、南非(9/18)、埃及(7/14)和约旦(8/16)的病例中占50%,阿拉伯联合酋长国(6/10)的病例中占60%,澳大利亚(11/16)的病例中占70%,哥斯达黎加(34/42)的病例中占81%,伊朗(7/8)的病例中占88%,希腊(20/22)的病例中占90%,肯尼亚的56例病例中占100%。利用存档组织建立了一种基于聚合酶链反应的敏感EBV毒株分型技术。结果显示,EBV 1型在来自英国、南非、澳大利亚和希腊的儿童霍奇金病中占主导地位。2型在埃及占主导地位。在英国、哥斯达黎加和肯尼亚的一些儿童霍奇金病病例中同时检测到了EBV 1型和2型。EBV的高发病率,尤其是在发展中国家同时存在1型和2型双重感染的情况,可能反映了导致营养不良性免疫损害的社会经济状况。HIV感染的可能性也需要进一步探讨。